Genome Therapeutics Ltd
12392992
Healthy
- 1 outstanding charge (-2)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 06/06/2024
INVESTOR
BRITISH · UNITED KINGDOM · Age 60
Also on 1 other board
director · Since 08/08/2025
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 55
Also on 9 other boards
Persons with Significant Control
Former PSCs
Prof Sir Shankar Balasubramanian
Ceased 08/08/2025
Dr Bobby Satyadev Yerramilli-Rao
Ceased 29/01/2020
Dr Samuel Aparicio
Ceased 18/10/2024
Dr Samuel Aparicio
Ceased 08/08/2025
Charges1 outstanding
HSBC INNOVATION BANKING
SILICON VALLEY BANK
CompanyRankvs 331+ SIC 72110 peers66
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/06/2025
Net Worth
£365k
Balance sheet strength
Cash
£363k
Cash in the bank
Net Current Assets
£299k
Working capital
Current Assets
£577k
Current Liabilities
£278k
Fixed Assets
£66k
Debtors
£214k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 2.08 | -£1.3M |
| 2024 | 6.03 | — |
| 2022 | 29.06 | +£2.0M |
Derived from filed accounts. Not audited figures.